Scope:

Given the safety and tolerability profiles associated with current osteoporosis therapies, as well as the low drug-treatment and compliance rates, significant unmet need remains in the field of osteoporosis. A number of novel osteoporosis therapies are set to launch over the next five years, and it is anticipated that they may at least partially address current unmet needs. 


Related Reports

Osteoporosis | Landscape & Forecast | Disease Landscape & Forecast

With an increasing prevalence, due to aging populations, the major-market osteoporosis patient pool is large and growing. The combined influence of increased patient numbers and drug launches wil...

View Details

Osteoporosis | Unmet Need | Detailed, Expanded Analysis (US/EU)

Patients with osteoporosis have an increased risk of fractures owing to a loss in bone strength. A significant unmet need exists for treatment that is more effective than current therapies and we...

View Details

Osteoporosis | Epidemiology | Epidemiology Dashboard

DRG Epidemiology's coverage of osteoporosis comprises epidemiological estimates of key patient populations across 45 countries worldwide. We repo...

View Details

Osteoporosis | Epidemiology | Extrapolated Worldwide Coverage

DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key osteoporosis patient p...

View Details